GLOBAL RECALL: Zerbaxa (ceftolozane / tazobactam) 1 g/0.5 g powder for concentrate for solution for infusion

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Active substance
  • Ceftolozane
  • tazobactam
Therapeutic area (MeSH)
Bacterial Infections
Procedure number
EMEA/H/C/003772
DHPC type
Quality defect
Human ATC code
J01
Dissemination date
23/12/2020

How useful was this page?

Add your rating